People like me who deal with diabetes every day on the Internet know that the hucksters are targeting us more and more with their scams and schemes. For people in business, diabetes has a well-deserve reputation as a growth industry. [Read more →]

I’m not a doctor, and I don’t play one on the Web, TV, or otherwise. But I just posed as one. It was in a good cause.

I am a journalist specializing in writing and consulting about diabetes. My highest university degree is a master’s. My credentials are my experience of a dozen years of having and studying diabetes and writing about it. [Read more →]

Almost four years ago in my “Diabetes Update” newsletter I wrote about an ancient remedy that is being used again to treat stubborn wounds and ulcers. These ulcers are a major threat to anybody with diabetes who has neuropathy. [Read more →]

When my former doctor diagnosed my diabetes, I wanted to find out as much about it as I could. So just one month later I got an Internet account. [Read more →]

The second generation of blood glucose meters is beginning to arrive. But it may not be what most people think it is.

It may not be continuous sensors, some of which are already here. They show our blood glucose trends and can warn of us impending hypos or hypers even while we are asleep. But few people with diabetes can afford them, because hardly any health insurance companies will reimburse you for them. [Read more →]

I’m here to advocate the Advocate.

Specifically, I am delighted with the talking version of the Advocate Duo meter. It tests blood glucose and blood pressure in a tiny and attractive – and inexpensive – little device. [Read more →]

Science is too big for one person working alone in a laboratory. It’s “a group effort,” as even the most recent winner of the Nobel Prize in Medicine, Andrew Z. Fire, said this week. [Read more →]

It seems like I get a new blood glucose meter just about every week. The latest is the GlucoLab, which HMD BioMedical LLC in Titusville, Florida, has started to distribute in the U.S. [Read more →]

Right now I’m disinvesting. I sold my AMLN shares today.

AMLN is the NASDAQ stock symbol for Amylin Pharmaceuticals Inc. in San Diego, which developed Byetta. [Read more →]